[To evaluate the neutralizing abilities of anti-dengue virus antibodies with nonstructural protein 1 antigen capture enzyme-linked immunosorbent assay]
- PMID: 20021846
[To evaluate the neutralizing abilities of anti-dengue virus antibodies with nonstructural protein 1 antigen capture enzyme-linked immunosorbent assay]
Abstract
Objective: To produce neutralizing antibodies against envelope protein domain III (EDIII) of dengue virus serotype I (DENV-1) and evaluate the nonstructural protein 1 (NS1) antigen capture enzyme-linked immunosorbent assay (ELISA) for identification of antibody neutralizing abilities.
Methods: Five BALB/c mice and one New Zealand Rabbit were immunized with recombinant EDIII protein of DENV-1 for the production of hybridomas and hyperimmune sera. Indirect ELISA, immunofluorescence assay (IFA) and Western Blot analyses were applied to identify specificity of antibodies. Comparing to plaque reduction neutralization test (PRNT), the new established DENV-1 specific NS1 antigen capture ELISA was used for detecting the neutralizing abilities of these antibody.
Results: Four strains of monoclonal antibodies (mAbs) named 1A1, 1B3, 3D3 and 9D6 and one hyperimmune serum of rabbit were obtained, all of which were approved to have neutralizing abilities to DENV-1 with the PRNT titer of 1:1024, 1:512, 1:256, 1:4096 and 1:4096. MAb 3D3 with the lowest neutralization titer in PRNT had not shown neutralizing ability to DENV-1 in NS1 antigen capture ELISA, while MAbs 1A1, 1B3 and 9D6 and the rabbit hyperimmune serum could protect the C6/36 from being infected by DENV-1 with the neutralization titer of 1:32, 1:32, 1:128 and 1:128 in this assay.
Conclusion: NS1 antigen capture ELISA could be used to identify antibody neutralizing abilities to DENV, it was a faster and more convenient way to screen antibodies with high neutralization titer and might also be used as one of the methods to evaluate the effects of vaccines.
Similar articles
-
[Production and characterization of the monoclonal antibodies against nonstructural 1 protein of DENV-4].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jul;27(7):777-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011. PMID: 21722533 Chinese.
-
[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].Mikrobiyol Bul. 2010 Jul;44(3):415-24. Mikrobiyol Bul. 2010. PMID: 21063991 Turkish.
-
Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).J Virol Methods. 2015 Sep 15;222:214-23. doi: 10.1016/j.jviromet.2015.06.003. Epub 2015 Jun 9. J Virol Methods. 2015. PMID: 26070890
-
The development of therapeutic antibodies against dengue virus.Antiviral Res. 2016 Apr;128:7-19. doi: 10.1016/j.antiviral.2016.01.002. Epub 2016 Jan 19. Antiviral Res. 2016. PMID: 26794397 Review.
-
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses.Viral Immunol. 2008 Jun;21(2):123-32. doi: 10.1089/vim.2008.0007. Viral Immunol. 2008. PMID: 18476771 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials